Although there is no commercially available vaccine for<unk>  fever, it is notable that infection with one serotype is thought to produce lifelong immunity to that type, but only short term protection against the other three.  Unfortunately, the risk of severe disease from secondary infection actually increases if someone previously exposed to serotype DENV-1 contracts serotype DENV-2 or DENV-3, or if someone previously exposed to DENV-3 acquires DENV-2.
Dengue fever secondary prevention
Chikungunya primary prevention
Bourbon virus infection secondary prevention
Zika virus infection medical therapy
Rocky Mountain spotted fever secondary prevention
Yellow fever primary prevention
Marburg hemorrhagic fever secondary prevention
Lassa fever medical therapy